Epoch Investment Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.7M Sell
37,880
-2,053
-5% -$703K 0.08% 203
2026
Q1
$14.1M Sell
39,933
-1,217
-3% -$434K 0.09% 202
2025
Q4
$13.5M Sell
41,150
-1,639
-4% -$520K 0.08% 194
2025
Q3
$12.1M Sell
42,789
-820
-2% -$238K 0.07% 202
2025
Q2
$12.2M Buy
43,609
+2,985
+7% +$846K 0.06% 199
2025
Q1
$12.7M Sell
40,624
-17,640
-30% -$5.21M 0.07% 201
2024
Q4
$15.2M Sell
58,264
-4,433
-7% -$1.32M 0.07% 186
2024
Q3
$20.2M Sell
62,697
-1,328
-2% -$434K 0.09% 189
2024
Q2
$20M Sell
64,025
-2,135
-3% -$627K 0.09% 193
2024
Q1
$18.8M Sell
66,160
-2,710
-4% -$793K 0.08% 204
2023
Q4
$19.8M Sell
68,870
-62,821
-48% -$17.1M 0.09% 214
2023
Q3
$35.4M Buy
131,691
+4,839
+4% +$1.21M 0.23% 150
2023
Q2
$28.2M Sell
126,852
-12,462
-9% -$2.89M 0.16% 179
2023
Q1
$33.7M Buy
139,314
+6,894
+5% +$1.69M 0.2% 164
2022
Q4
$34.8M Sell
132,420
-234,429
-64% -$62.8M 0.21% 154
2022
Q3
$82.7M Sell
366,849
-7,045
-2% -$1.71M 0.54% 54
2022
Q2
$91M Sell
373,894
-81,972
-18% -$20.1M 0.53% 56
2022
Q1
$110M Buy
455,866
+6,789
+2% +$1.56M 0.54% 52
2021
Q4
$101M Buy
449,077
+19,349
+5% +$4.08M 0.51% 56
2021
Q3
$91.4M Sell
429,728
-298,879
-41% -$68.8M 0.51% 64
2021
Q2
$178M Sell
728,607
-111,033
-13% -$27.3M 0.95% 24
2021
Q1
$209M Buy
839,640
+47,787
+6% +$11.4M 0.98% 22
2020
Q4
$182M Sell
791,853
-107,726
-12% -$24.8M 0.84% 33
2020
Q3
$229M Sell
899,579
-92,633
-9% -$22.9M 1.14% 16
2020
Q2
$234M Sell
992,212
-53,938
-5% -$12.3M 1.21% 15
2020
Q1
$212M Sell
1,046,150
-196,019
-16% -$42.8M 1.29% 15
2019
Q4
$299M Buy
1,242,169
+133,689
+12% +$29.5M 1.29% 12
2019
Q3
$215M Buy
1,108,480
+394,030
+55% +$75.6M 0.98% 30
2019
Q2
$132M Buy
714,450
+27,744
+4% +$4.97M 0.59% 67
2019
Q1
$130M Buy
686,706
+162,330
+31% +$31M 0.57% 69
2018
Q4
$102M Buy
524,376
+441,995
+537% +$86.2M 0.47% 77
2018
Q3
$17.1M Sell
82,381
-19,661
-19% -$3.87M 0.06% 195
2018
Q2
$18.8K Sell
102,042
-8,142
-7% -$1.44M 0.06% 196
2018
Q1
$18.8M Sell
110,184
-3,293
-3% -$604K 0.07% 191
2017
Q4
$19.7M Buy
113,477
+12,516
+12% +$2.22M 0.07% 189
2017
Q3
$18.8M Buy
+100,961
New +$17.9M 0.06% 191

Other funds holding AMGN

Epoch Investment Partners's AMGN Position: Q2 2026 in Review

Epoch Investment Partners reduced its Amgen (AMGN) stake by 5.1% in Q2 2026, selling an estimated $703K and leaving 37,880 shares worth $13.7M. The position accounts for 0.08% of the portfolio, ranked #203.

Epoch Investment Partners first reported a position in AMGN in Q3 2017 and has held it in 36 quarters since. The position peaked at $299M in Q4 2019. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Epoch Investment Partners held 37,880 shares of Amgen worth $13.7M as of Q2 2026.
  • Epoch Investment Partners sold 2,053 Amgen shares in Q2 2026, an estimated $703K.
  • Amgen made up 0.08% of Epoch Investment Partners's portfolio in Q2 2026, its #203 holding.
  • Epoch Investment Partners first reported a position in Amgen in Q3 2017 and has held it in 36 quarters since.
  • Epoch Investment Partners's Amgen position peaked at $299M in Q4 2019.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Epoch Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.